C-RAD AB C-RAD AB announced a new order for Catalyst+HD™? and Sentinel 4DCT™? from Australian Cancer Care Associates (CCA).
The order includes multiple systems across the CCA network. Cancer Care Associates (CCA) is an expanding Australian owned comprehensive cancer care provider. CCA is renowned for providing high quality patient care and the addition of C-RAD's radiation therapy systems across the organisation will enhance accuracy and efficiency of patient treatment.
The total order value is approximately SEK 23 Million and includes multiple Catalyst+HD and Sentinel systems across the C CA network. Delivery and installation are expected to take place over the coming two years, starting second half of 2023.
